These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2934516)

  • 61. Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
    Ribas C; Miralles A; Escribá PV; García-Sevilla JA
    Eur J Pharmacol; 1998 Jun; 351(1):145-54. PubMed ID: 9698216
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat.
    Fuxe K; Agnati LF; Merlo Pich E; Meller E; Goldstein M
    Neurosci Lett; 1987 Oct; 81(1-2):183-7. PubMed ID: 3320818
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex.
    Adler CH; Meller E; Goldstein M
    J Pharmacol Exp Ther; 1987 Feb; 240(2):508-15. PubMed ID: 3027315
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A; Minneman KP
    Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.
    Wenk GL; Engisch KL
    J Neurochem; 1986 Sep; 47(3):845-50. PubMed ID: 2942641
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J; Lakoski JM
    Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.
    Wouters W; Janssen CG; Van Dun J; Thijssen JB; Laduron PM
    J Med Chem; 1986 Sep; 29(9):1663-8. PubMed ID: 3746815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Photoaffinity probes for serotonin and histamine receptors. Synthesis and characterization of two azide analogues of ketanserin.
    Wouters W; Van Dun J; Leysen JE; Laduron PM
    J Biol Chem; 1985 Jul; 260(14):8423-9. PubMed ID: 3874207
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo binding of SCH 39166: a D-1 selective antagonist.
    McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 5-HT2 receptors, roles and regulation.
    Leysen JE; Pauwels PJ
    Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
    Ekman A; Eriksson E
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):152-7. PubMed ID: 1360151
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A high dose of EEDQ reduces pituitary dopamine D2 receptor density and the prolactin suppressive potency of agonists.
    Ekman A; Eriksson E
    Eur J Pharmacol; 1993 Oct; 243(3):295-9. PubMed ID: 7903944
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
    Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    Pinto W; Battaglia G
    Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
    Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
    Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
    [TBL] [Abstract][Full Text] [Related]  

  • 78. pH-dependent modulation of agonist interactions with [3H]-ketanserin-labelled S2 serotonin receptors.
    Battaglia G; Shannon M; Borgundvaag B; Titeler M
    Life Sci; 1983 Nov; 33(20):2011-6. PubMed ID: 6645787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serotonin-S2 receptor binding sites and functional correlates.
    Leysen JE; de Chaffoy de Courcelles D; De Clerck F; Niemegeers CJ; Van Nueten JM
    Neuropharmacology; 1984 Dec; 23(12B):1493-501. PubMed ID: 6396526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.